Inventaire - your friends and communities are your best library

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

author

Ronald van Vollenhoven

1960 -

published in: The BMJ

date of publication: 2015-04-09

language: English

main subject: adalimumab, rheumatoid arthritis

Cites articles 22

Date

Title

Authors

2014-09-29

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Ronald van Vollenhoven, Alfons A den Broeder
2014-04-01

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

Liana Fraenkel, Jeffrey N Katz, Daniel H Solomon
2013-10-24

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study

Ronald van Vollenhoven, Alfons A den Broeder
2013-05-30

Biologic discontinuation studies: a systematic review of methods

Kazuki Yoshida, Sang-Cheol Bae, Daniel H Solomon, Michael E Weinblatt, Arthur Kavanaugh
2013-01-17

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Karel Pavelka, Peter Nash, Min-Chan Park, Bonnie Vlahos, Patrick Durez, Annette Szumski
2013-10-26

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

Karel Pavelka, Paul Emery, Ronald van Vollenhoven, Josef S Smolen, Arthur Kavanaugh, Patrick Durez
2013-04-20

Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited
2013-08-01

Public biotech 2012--the numbers
2012-07-06

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus

Susan J. Bartlett, Vibeke Strand, Annelies Boonen, Tessa Sanderson, Vivian P Bykerk
2012-11-23

Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study

Alfons A den Broeder
2011-10-01

Achieving tight control in rheumatoid arthritis
2011-12-30

A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry

Alfons A den Broeder
2010-10-01

Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 compariso
2009-11-02

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

Peter Tugwell, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Jasvinder Singh, George Wells, Maria E Suarez-Almazor, Robin Christensen
2009-04-28

Contemporary treatment principles for early rheumatoid arthritis: a consensus statement

Philip G Conaghan, Richard J. Wakefield
2008-11-19

Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
2007-01-29

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

Solbritt Rantapää-Dahlqvist, Ronald van Vollenhoven, Lars Klareskog, Lena Brandt, Pierre Geborek, Tore Saxne, Eva Baecklund, Nils Feltelius, Staffan Lindblad, Johan Askling, Lars Costers
2006-05-01

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

Victor Montori, Iain Buchan, Michael J Sweeting, Alex J Sutton
2006-03-01

Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective
2004-07-01

The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis

Sjef van der Linden, Désirée van der Heijde
2002-04-01

Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference

Sjef van der Linden, Désirée van der Heijde, Annelies Boonen
2000-01-01

How to read radiographs according to the Sharp/van der Heijde method

Article - wd:Q35348182

Welcome to Inventaire

the library of your friends and communities

learn more